These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 29774135)

  • 1. Vemurafenib in Langerhans cell histiocytosis: report of a pediatric patient and review of the literature.
    Heisig A; Sörensen J; Zimmermann SY; Schöning S; Schwabe D; Kvasnicka HM; Schwentner R; Hutter C; Lehrnbecher T
    Oncotarget; 2018 Apr; 9(31):22236-22240. PubMed ID: 29774135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vemurafenib combined with chemotherapy achieved sustained remission in pediatric LCH: a multi-center observational study.
    Lei J; Wang W; Lin D; Zhu C; Jia W; Weng W; Liu X; Ma Y; Wang Z; Yang L; He X; He Y; Li Y
    J Cancer Res Clin Oncol; 2024 Jan; 150(1):12. PubMed ID: 38231288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted Therapy With Vemurafenib in Brazilian Children With Refractory Langerhans Cell Histiocytosis: Two Case Reports and Review of Literature.
    Silva KAS; Magalhães IMQS; Benincasa DER; Cecconello DK; Michalowski MB
    Cancer Rep (Hoboken); 2024 Aug; 7(8):e2142. PubMed ID: 39190425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of vemurafenib in Langerhans cell histiocytosis (LCH): A systematic review and meta-analysis.
    Mohapatra D; Gupta AK; Haldar P; Meena JP; Tanwar P; Seth R
    Pediatr Hematol Oncol; 2023 Feb; 40(1):86-97. PubMed ID: 35616365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vemurafenib in refractory langerhans histiocytosis].
    Raciborska A; Małas Z; Tysarowski A
    Dev Period Med; 2018; 22(4):376-378. PubMed ID: 30636236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vemurafenib acts as a molecular on-off switch governing systemic inflammation in Langerhans cell histiocytosis.
    Eder SK; Schwentner R; Ben Soussia P; Abagnale G; Attarbaschi A; Minkov M; Halbritter F; Hutter C
    Blood Adv; 2022 Feb; 6(3):970-975. PubMed ID: 34619771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vemurafenib combined with cladribine and cytarabine results in durable remission of pediatric BRAF V600E-positive LCH.
    Evseev D; Osipova D; Kalinina I; Raykina E; Ignatova A; Lyudovskikh E; Baidildina D; Popov A; Zhogov V; Semchenkova A; Litvin E; Kotskaya N; Cherniak E; Voronin K; Burtsev E; Bronin G; Vlasova I; Purbueva B; Fink O; Pristanskova E; Dzhukaeva I; Erega E; Novichkova G; Maschan A; Maschan M
    Blood Adv; 2023 Sep; 7(18):5246-5257. PubMed ID: 37216396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case Report: Early Association of Vemurafenib to Standard Chemotherapy in Multisystem Langerhans Cell Histiocytosis in a Newborn: Taking a Chance for a Better Outcome?
    Gaspari S; Di Ruscio V; Stocchi F; Carta R; Becilli M; De Ioris MA
    Front Oncol; 2021; 11():794498. PubMed ID: 34966688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Langerhans cell histiocytosis in children: from the bench to bedside for an updated therapy.
    Aricò M
    Br J Haematol; 2016 Jun; 173(5):663-70. PubMed ID: 26913480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group.
    Minkov M; Grois N; Heitger A; Pötschger U; Westermeier T; Gadner H
    Klin Padiatr; 2000; 212(4):139-44. PubMed ID: 10994540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective rescue treatment with vemurafenib of an infant with high-risk Langerhans cell histiocytosis.
    Gerbaux M; Diallo S; Dedeken L; Dangoisse C; Bott A; Heritier S; Salik D; Ferster A
    Ann Dermatol Venereol; 2020 Nov; 147(11):782-785. PubMed ID: 32653217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vinblastine chemotherapy in adult patients with langerhans cell histiocytosis: a multicenter retrospective study.
    Tazi A; Lorillon G; Haroche J; Neel A; Dominique S; Aouba A; Bouaziz JD; de Margerie-Melon C; Bugnet E; Cottin V; Comont T; Lavigne C; Kahn JE; Donadieu J; Chevret S
    Orphanet J Rare Dis; 2017 May; 12(1):95. PubMed ID: 28532436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Langerhans cell histiocytosis.
    Grana N
    Cancer Control; 2014 Oct; 21(4):328-34. PubMed ID: 25310214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Langerhans cell histiocytosis: role of BRAF/MAPK inhibition.
    Abla O; Weitzman S
    Hematology Am Soc Hematol Educ Program; 2015; 2015():565-70. PubMed ID: 26637773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary oral manifestation of Langerhans cell histiocytosis refractory to conventional therapy but susceptible to BRAF-specific treatment: a case report and review of the literature.
    Neckel N; Lissat A; von Stackelberg A; Thieme N; Doueiri MS; Spors B; Beck-Broichsitter B; Heiland M; Raguse JD
    Ther Adv Med Oncol; 2019; 11():1758835919878013. PubMed ID: 31666812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment results of Langerhans cell histiocytosis with LSH II protocol].
    Mottl H; Ganevová M; Radvanská J; Chánová M; Smelhaus V; Kodet R; Mrhalová M; Tichý M
    Cas Lek Cesk; 2005; 144(11):753-5. PubMed ID: 16335702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiating skin-limited and multisystem Langerhans cell histiocytosis.
    Simko SJ; Garmezy B; Abhyankar H; Lupo PJ; Chakraborty R; Lim KP; Shih A; Hicks MJ; Wright TS; Levy ML; McClain KL; Allen CE
    J Pediatr; 2014 Nov; 165(5):990-6. PubMed ID: 25441388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of children with multiple system Langerhans cell histiocytosis by Japan Langerhans Cell Histiocytosis Study Group Protocol].
    Huang JB; Xue HM; Chen YY; Huang K
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):146-9. PubMed ID: 23484709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic stem cell transplantation (HSCT) for Langerhans cell histiocytosis (LCH) in Japan.
    Kinugawa N; Imashuku S; Hirota Y; Yamada K; Yamamoto A; Akazai A; Oda M; Miura N; Kakuta H; Sato T; Endo M; Takano T
    Bone Marrow Transplant; 1999 Oct; 24(8):935-8. PubMed ID: 10516710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Langerhans cell histiocytosis of the temporal bone: A review of 29 cases at a single center.
    Modest MC; Garcia JJ; Arndt CS; Carlson ML
    Laryngoscope; 2016 Aug; 126(8):1899-904. PubMed ID: 26535795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.